@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix n: <https://nap.nprod.net/> .
@prefix text: <http://jena.apache.org/text#> .

# Test compounds
<https://nap.nprod.net/compound/1> rdf:type n:compound ;
    n:name "Aspirin" ;
    n:number "1" ;
    n:compoundclass "Salicylate" ;
    n:publicationCode "ASP001" ;
    n:publicationName "Aspirin Publication" .

<https://nap.nprod.net/compound/2> rdf:type n:compound ;
    n:name "Caffeine" ;
    n:number "2" ;
    n:compoundclass "Xanthine" ;
    n:publicationCode "CAF001" ;
    n:publicationName "Caffeine Study" .

<https://nap.nprod.net/compound/3> rdf:type n:compound ;
    n:name "Morphine" ;
    n:number "3" ;
    n:compoundclass "Alkaloid" ;
    n:publicationCode "MOR001" ;
    n:publicationName "Morphine Research" .

# Test compound synonyms
<https://nap.nprod.net/compoundsynonym/1> n:synonym "Acetylsalicylic acid" ;
    n:has_synonym <https://nap.nprod.net/compound/1> .

<https://nap.nprod.net/compoundsynonym/2> n:synonym "1,3,7-trimethylxanthine" ;
    n:has_synonym <https://nap.nprod.net/compound/2> .

# Test organisms
<https://nap.nprod.net/organism/1> rdf:type n:organism ;
    n:name "Salix alba" ;
    n:familyname "Salicaceae" ;
    n:genusname "Salix" ;
    n:speciesname "alba" ;
    n:speciesauthority "L." ;
    n:organismclass "Plantae" ;
    n:comment "White willow tree" .

<https://nap.nprod.net/organism/2> rdf:type n:organism ;
    n:name "Coffea arabica" ;
    n:familyname "Rubiaceae" ;
    n:genusname "Coffea" ;
    n:speciesname "arabica" ;
    n:speciesauthority "L." ;
    n:organismclass "Plantae" ;
    n:comment "Coffee plant" .

<https://nap.nprod.net/organism/3> rdf:type n:organism ;
    n:name "Papaver somniferum" ;
    n:familyname "Papaveraceae" ;
    n:genusname "Papaver" ;
    n:speciesname "somniferum" ;
    n:speciesauthority "L." ;
    n:organismclass "Plantae" ;
    n:comment "Opium poppy" .

# Test geographical areas
<https://nap.nprod.net/geographicalarea/1> rdf:type n:geographicalarea ;
    n:name "Europe" ;
    n:code "EU" .

<https://nap.nprod.net/geographicalarea/2> rdf:type n:geographicalarea ;
    n:name "South America" ;
    n:code "SA" .

<https://nap.nprod.net/country/1> rdf:type n:country ;
    n:name "Germany" ;
    n:code "DE" .

<https://nap.nprod.net/country/2> rdf:type n:country ;
    n:name "Brazil" ;
    n:code "BR" .

# Link organisms to geographical areas
<https://nap.nprod.net/organism/1> n:collectedFrom <https://nap.nprod.net/geographicalarea/1> .
<https://nap.nprod.net/organism/2> n:collectedFrom <https://nap.nprod.net/geographicalarea/2> .
<https://nap.nprod.net/organism/3> n:collectedFrom <https://nap.nprod.net/geographicalarea/1> .

# Test worktypes
<https://nap.nprod.net/worktype/1> rdf:type n:worktype ;
    n:name "Anti-inflammatory activity" ;
    n:code "AI" ;
    n:has_group <https://nap.nprod.net/worktypegroup/1> .

<https://nap.nprod.net/worktype/2> rdf:type n:worktype ;
    n:name "CNS stimulant activity" ;
    n:code "CNS" ;
    n:has_group <https://nap.nprod.net/worktypegroup/2> .

<https://nap.nprod.net/worktype/3> rdf:type n:worktype ;
    n:name "Analgesic activity" ;
    n:code "AN" ;
    n:has_group <https://nap.nprod.net/worktypegroup/3> .

# Test worktype groups
<https://nap.nprod.net/worktypegroup/1> rdf:type n:worktypegroup ;
    n:name "Inflammatory disorders" ;
    n:code "INFLAM" .

<https://nap.nprod.net/worktypegroup/2> rdf:type n:worktypegroup ;
    n:name "Central nervous system" ;
    n:code "CNS" .

<https://nap.nprod.net/worktypegroup/3> rdf:type n:worktypegroup ;
    n:name "Pain management" ;
    n:code "PAIN" .

# Test pharmacology activities
<https://nap.nprod.net/pharmacology/1> rdf:type n:pharmacology ;
    n:name "Anti-inflammatory effect" ;
    n:disease "Inflammation" .

<https://nap.nprod.net/pharmacology/2> rdf:type n:pharmacology ;
    n:name "Stimulant effect" ;
    n:disease "Fatigue" .

<https://nap.nprod.net/pharmacology/3> rdf:type n:pharmacology ;
    n:name "Analgesic effect" ;
    n:disease "Pain" .

# Test pharmacy experiments (central hub)
<https://nap.nprod.net/pharmacy/1> rdf:type n:pharmacy ;
    n:number "1" ;
    n:has_organism <https://nap.nprod.net/organism/1> ;
    n:has_participant <https://nap.nprod.net/compound/1> ;
    n:has_pharmacology <https://nap.nprod.net/pharmacology/1> ;
    n:has_worktype <https://nap.nprod.net/worktype/1> ;
    n:doseamount "500" ;
    n:activitylevel "High" ;
    n:disease "Inflammation" ;
    n:cmpdiso "Test cmpdiso 1" ;
    n:cmpdisounit "mg/kg" ;
    n:rawyield "85.5" ;
    n:amtutilunit "grams" ;
    n:pharmactivity "Anti-inflammatory" ;
    n:percentyield "85.5" ;
    n:quantitativeresult "Significant" ;
    n:amtutil "100" ;
    n:administeredBy <https://nap.nprod.net/administrationroute/1> .

<https://nap.nprod.net/pharmacy/2> rdf:type n:pharmacy ;
    n:number "2" ;
    n:has_organism <https://nap.nprod.net/organism/2> ;
    n:has_participant <https://nap.nprod.net/compound/2> ;
    n:has_pharmacology <https://nap.nprod.net/pharmacology/2> ;
    n:has_worktype <https://nap.nprod.net/worktype/2> ;
    n:doseamount "100" ;
    n:activitylevel "Moderate" ;
    n:disease "Fatigue" ;
    n:cmpdiso "Test cmpdiso 2" ;
    n:cmpdisounit "mg/ml" ;
    n:rawyield "92.3" ;
    n:amtutilunit "grams" ;
    n:pharmactivity "Stimulant" ;
    n:percentyield "92.3" ;
    n:quantitativeresult "Moderate" ;
    n:amtutil "50" ;
    n:administeredBy <https://nap.nprod.net/administrationroute/1> .

<https://nap.nprod.net/pharmacy/3> rdf:type n:pharmacy ;
    n:number "3" ;
    n:has_organism <https://nap.nprod.net/organism/3> ;
    n:has_participant <https://nap.nprod.net/compound/3> ;
    n:has_pharmacology <https://nap.nprod.net/pharmacology/3> ;
    n:has_worktype <https://nap.nprod.net/worktype/3> ;
    n:doseamount "10" ;
    n:activitylevel "High" ;
    n:disease "Pain" ;
    n:cmpdiso "Test cmpdiso 3" ;
    n:cmpdisounit "mg/dose" ;
    n:rawyield "78.9" ;
    n:amtutilunit "milligrams" ;
    n:pharmactivity "Analgesic" ;
    n:percentyield "78.9" ;
    n:quantitativeresult "High" ;
    n:amtutil "25" ;
    n:administeredBy <https://nap.nprod.net/administrationroute/2> .

# Test citations
<https://nap.nprod.net/citation/1> rdf:type n:citation ;
    n:title "Salicin from willow bark: anti-inflammatory properties" ;
    n:authors "Smith, J.; Brown, A.; Wilson, K." ;
    n:year "2020" ;
    n:journal "Journal of Natural Products" ;
    n:volume "83" ;
    n:issue "4" ;
    n:pages "1234-1245" ;
    n:doi "10.1021/acs.jnatprod.0c00123" .

<https://nap.nprod.net/citation/2> rdf:type n:citation ;
    n:title "Caffeine metabolism and CNS effects" ;
    n:authors "Johnson, M.; Davis, L." ;
    n:year "2019" ;
    n:journal "Drug Metabolism Reviews" ;
    n:volume "51" ;
    n:issue "2" ;
    n:pages "567-589" ;
    n:doi "10.1080/03602532.2019.1234567" .

<https://nap.nprod.net/citation/3> rdf:type n:citation ;
    n:title "Opium alkaloids: pharmacology and therapeutic use" ;
    n:authors "Garcia, R.; Martinez, P.; Lopez, C." ;
    n:year "2021" ;
    n:journal "Pain Medicine" ;
    n:volume "22" ;
    n:issue "8" ;
    n:pages "1890-1905" ;
    n:doi "10.1093/pm/pnab123" .

# Link organisms to citations
<https://nap.nprod.net/organism/1> n:participatesIn <https://nap.nprod.net/citation/1> .
<https://nap.nprod.net/organism/2> n:participatesIn <https://nap.nprod.net/citation/2> .
<https://nap.nprod.net/organism/3> n:participatesIn <https://nap.nprod.net/citation/3> .

# Test administration routes
<https://nap.nprod.net/administrationroute/1> rdf:type n:administrationroute ;
    n:name "Oral" ;
    n:code "PO" .

<https://nap.nprod.net/administrationroute/2> rdf:type n:administrationroute ;
    n:name "Intravenous" ;
    n:code "IV" .

<https://nap.nprod.net/administrationroute/3> rdf:type n:administrationroute ;
    n:name "Topical" ;
    n:code "TOP" .